Certified Cannabis Medicine

We have known about the patent for neuroprotection and anti-oxidants related to CBD for years now. The Federal Government patented CBD for this and other potential health benefits. The US Patent # = 6630507

There are also many OTHER patents on cannabis that I recently found on:
2304669 1942 Isolation of cannabidiol – 20110217.005017
2354492 1944 Marihuana active compound – 20110217.005419
2419934 1947 Optically active tetrahydrodibenzopyrans having marihuana activity and process for .. – 20110217.010128
2419935 1947 Marihuana active compounds – 20110217.010934
2419936 1947 Preparation of compounds with marihuana activity – 20110217.011517
2509386 1950 Dibenzopyran marihuana-like compounds – 20110217.012129
2509387 1950 Dibenzopyran marihuana-like compounds – 20110217.012513
3668224 1972 Process of producing 6a, 10a-trans-6a,7,8,10a-tetrahydrodibenzo (b,d)-pyrans – 20110217.013244
3728360 1973 Ester derivatives of tetrahydrocannabinol – 20110217.013646
3734930 1973 Direct synthesis of (-)-trans-delta-9-tetrahydrocannabinol from olivetol and (+)-tr.. – 20110217.005434
4025516 1977 Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-p.. – 20110217.022419
4116979 1978 Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-p.. – 20110217.030800
4126694 1978 Composition and method for treating glaucoma – 20110217.031302
4126695 1978 Anti-glaucoma composition and method – 20110217.031624
4179517 1979 Novel tetrahydrocannabinol type compounds – 20110217.032121
4189491 1980 Tetrahydrocannabinol in a method of treating glaucoma – 20110217.032351
4195078 1980 Nabilone granulation – 20110219.131638
4279824 1981 Method and apparatus for processing herbaceous plant materials including the plant .. – 20110221.005824
4315862 1982 Process for preparing cannabichromene – 20110219.132528
4327028 1982 Composition of matter – 20110219.132854
4464378 1984 Method of administering narcotic antagonists and analgesics – 20110219.134318
4476140 1984 Composition and method for treatment of glaucoma – 20110219.133925
4758597 1988 Carenadiol and derivatives – 20110220.235422
4837228 1989 Antiinflammatory and antimicrobial compounds and compositions – 20110219.135422
4847290 1989 Delta 1-thc-7-oic acid and analgesic and anti-inflammatory agents – 20110219.140914
4876276 1989 (3s-4s)-7-hydroxy-delta-6-tetrahydrocannabinols – 20110219.141600
4933363 1990 Method for effecting systemic delivery of delta-9-tetrahydrocannabinol – 20110219.144031
5227537 1993 Method for the production of 6,12-dihydro-6-hydroxy-cannabidiol and the use thereof.. – 20110221.005135
5237057 1993 Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol d.. – 20110219.144538
5292899 1994 Synthesis of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid glucuronide – 20110219.145249
5302703 1994 Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol d.. – 20110219.145809
5338753 1994 (3r,4r)-delta-6-tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents .. – 20110219.150617
5342971 1994 Process for the preparation of dibenzo[b,d]pyrans – 20110219.150655
5389375 1995 Stable suppository formulations effecting bioavailability of delta-9-thc – 20110219.151015
5440052 1995 Compositions useful as a cannabinoid receptor probe – 20110219.151453
5508037 1996 Stable suppository formulations effecting bioavailability of delta-9-thc – 20110219.151931
5532237 1996 Indole derivatives with affinity for the cannabinoid receptor – 20110219.152606
5538993 1996 Certain tetrahydrocannabinol-7-oic acid derivatives – 20110219.152901
5596106 1997 Cannabinoid receptor antagonists – 20110219.153207
5605906 1997 Cannabinoid receptor agonists – 20110219.153325
5605928 1997 Antiemetic compositions – 20110219.153523
5631297 1997 Anandamides useful for the treatment of intraocular hypertension… – 20110219.160906
5635530 1997 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processor.. – 20110219.154139
5688825 1997 Anandamide amidase inhibitors as analgesic agents – 20110219.161202
5716638 1998 Composition for applying active substances to or through the skin – 20110219.161548
5747524 1998 Cannabinoid receptor antagonists – 20110219.161846
5804592 1998 Method for improving disturbed behavior and elevating mood in humans – 20110219.162419
5847128 1998 Water soluble derivatives of cannabinoids – 20110219.162859
5872148 1999 Compositions useful as a cannabinoid receptor probe – 20110219.163222
5874459 1999 Anandamide amidase inhibitors as analgesic agents – 20110219.163805
5925768 1999 pyrazolecarboxamide derivatives having cannabinoid receptor affinity – 20110219.164326
5932610 1999 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals – 20110219.164744
5939429 1999 Cardiovascular uses of cannabinoid compounds – 20110219.164958
5948777 1999 Cannabinoid receptor agonists – 20110219.165232
5977180 1999 Anandamide analog compositions and method of treating intraocular hypertension usin.. – 20110219.165507
5990170 1999 Therapeutic use of mono and bicarboxylic acid amides active at the peripheral canna.. – 20110219.165901
6008383 1999 Method of preparing delta-9-tetrahydrocannabinol esters – 20110219.170127
6013648 2000 Cb2 receptor agonist compounds – 20110219.170359
6017919 2000 Compounds and pharmaceutical use thereof – 20110219.232239
6096740 2000 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions – 20110219.232844
6100259 2000 Cannabinoid receptor modulators – 20110219.233213
6113940 2000 Cannabinoid patch and method for cannabis transdermal delivery – 20110219.233850
6132762 2000 Transcutaneous application of marijuana – 20110219.234036
6162829 2000 (3r,4r)-delta-8-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents.. – 20110219.234311
6166066 2000 Cannabinoids selective for the cb2 receptor – 20110219.234631
6274635 2001 Alkylated resorcinol derivatives for the treatment of immune diseases – 20110219.235354
6284788 2001 Use of known agonists of the central cannabinoid receptor cb1 – 20110219.235654
6328992 2001 Cannabinoid patch and method for cannabis transdermal delivery – 20110220.000814
6331560 2001 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals – 20110220.002503
6344474 2002 Use of central cannabinoid receptor antagonists for regulating appetence – 20110220.002717
6355650 2002 (3r,4r)-delta-8-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents.. – 20110220.002953
6380175 2002 Method for enhancement of delivery of thc by the administration of its prodrugs via.. – 20110220.003309
6383513 2002 Compositions comprising cannabinoids – 20110220.003536
6391909 2002 Anandamide inhibitors as analgesic agents – 20110220.003752
6448288 2002 Cannabinoid drugs – 20110220.004111
6509005 2003 delta-9 tetrahydrocannabinol (delta-9 thc) solution metered dose inhaler – 20110220.010440
6509367 2003 Pyrazole cannabinoid agonist and antagonists – 20110220.010824
6545041 2003 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals – 20110220.011159
6563009 2003 Vasodilator cannabinoid analogs – 20110220.011723
6566560 2003 Resorcinolic compounds – 20110220.012340
6579900 2003 Anandamide amidase inhibitors as analgesic agents – 20110220.013014
6610737 2003 Non psychotropic cannabinoids – 20110220.013607
6630507 2003 Cannabinoids as antioxidants and neuroprotectants – 20110217.040403
6642258 2003 Use of central cannabinoid receptor antagonist for preparing medicines-20110220.141047
6653304 2003 Cannabinoid receptor modulators, their processes of preparation, and use of cannabi.. – 20110220.141700
6703418 2004 Appetite stimulation and induction of weight gain in patients suffering from sympto.. – 20110220.141926
6713048 2004 Delta-9 tetrahydrocannabinol (delta-9 thc) solution metered dose inhalers and metho.. – 20110220.142152
6747058 2004 Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol a.. – 20110220.142350
6825209 2004 Compounds having unique cb1 receptor binding selectivity and methods for their prod.. – 20110220.142627
6864291 2005 Agonists specific for the peripheral cannabinoid receptor – 20110220.142827
6900236 2005 Cannabimimetic indole derivatives – 20110220.143112
6903137 2005 Agonists specific for the peripheral cannabinoid receptor – 20110220.144738
6930122 2005 Use of central cannabinoid receptor antagonist for preparing medicines designed to .. – 20110220.225951
6939977 2005 Analgesic and immunomodulatory cannabinoids – 20110220.230157
6943266 2005 Bicyclic cannabinoid agonists for the cannabinoid receptor – 20110220.230355
6949582 2005 Method of relieving analgesia and reducing inflamation using a cannabinoid delivery.. – 20110220.230551
6974568 2005 Treatment for cough – 20110220.231124
6995187 2006 Peripheral cannabinoid receptor (cb2) selective ligands – 20110220.231316
7049329 2006 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof – 20110220.231649
7057076 2006 Bicyclic and tricyclic cannabinoids – 20110220.231942
7067539 2006 Cannabinoid receptor ligands – 20110220.232124
7071213 2006 Cannabinoid receptor ligands – 20110220.232329
7088914 2006 Device, method and resistive element for vaporizing a medicament – 20110220.232627
7105685 2006 Cannabinol derivatives – 20110220.232801
7109245 2006 Vasoconstrictor cannabinoid analogs – 20110220.233007
7119108 2006 Pyrazole derivatives as cannabinoid receptor antagonists – 20110220.233254
7129239 2006 Purine compounds and uses thereof – 20110220.233510
7141669 2006 Cannabiniod receptor ligands and uses thereof – 20110220.233811
7145012 2006 Cannabinoid receptor ligands and uses thereof – 20110220.234023
7161016 2007 Cannabimimetic lipid amides as useful medications – 20110220.234200
7169942 2007 Cannabinoid derivatives, methods of making, and use thereof – 20110220.234343
7173027 2007 Receptor selective cannabimimetic aminoalkylindoles – 20110220.234621
7176210 2007 Cannabinoid receptor ligands and uses thereof – 20110220.234841
7179800 2007 Cannabinoids – 20110220.235606
7183313 2007 Keto cannabinoids with therapeutic indications – 20110220.235821
7217732 2007 Cannabinoid receptor agonists – 20110221.000020
7220743 2007 Heterocyclic cb1 receptor antagonists – 20110221.000208
7229999 2007 Pyridine-3-carboxamide derivatives as cb1 inverse agonists – 20110221.000408
7232823 2007 Cannabinoid receptor ligands and uses thereof – 20110221.000602
7235584 2007 Non psychotropic cannabinoids – 20110221.000739
7241799 2007 Cannabimimetic indole derivatives – 20110221.000920
7247628 2007 Cannabinoid receptor ligands and uses thereof – 20110221.001058
7268133 2007 Cannabinoid receptor ligands and uses thereof – 20110221.001308
7276516 2007 Cb1 antagonist compounds – 20110221.002759
7276613 2007 Retro-anandamides, high affinity and stability cannabinoid receptor ligands – 20110221.002935
7285683 2007 Bicyclic and tricyclic cannabinoids – 20110221.003404
7285687 2007 Cannabinoids – 20110221.003830
7294644 2007 Cb 1 receptor inverse agonists – 20110221.004028
7321047 2008 Separation of tetrahydrocannabinols – 20110221.004243
7323576 2008 Synthetic route to dronabinol – 20110221.004441
7329651 2008 Cannabimimetic ligands – 20110221.004633
7329658 2008 Cannabinoid receptor ligands and uses thereof – 20110221.004825
7335688 2008 Bicyclic cannabinoid agonists for the cannabinoid receptor – 20110221.005006
7344736 2008 Extraction of pharmaceutically active components from plant materials – 20110221.005455
7354929 2008 Cannabinoid receptor ligands and uses thereof – 20110221.010029
7358245 2008 Treatment of gastroesophageal reflux disease – 20110221.010322
7393842 2008 Pyrazole analogs acting on cannabinoid receptors – 20110221.010732
7399872 2008 Conversion of cbd to delta-8-thc and delta-9-thc – 20110221.011142
7402686 2008 Cannabinoid crystalline derivatives and process of cannabinoid purification – 20110221.011644
7592328 2009 Natural cyclodextrin complexes – 20110221.011900
7592468 2009 Production of delta-9 tetrahydrocannabinol – 20110221.012444
7648696 2010 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous.. – 20110221.012955

Read more: http://xcannabis.com/2011/05/low-and-behold-they-want-to-reschedule-cannabis/#ixzz1PkGqO0Zm